RxDoctor Payments Data

Kimberly Bergeron, PA

Medical · Baton Rouge, LANPI 1609177161

Payments from drug & device makers

What this record shows

Boston Scientific accounts for 70.2% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2023 at $3,220 and has fallen 64.0% since, to $1,160 in 2025. Among medical clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,007in general payments, 2019–2025

Across 146 payments — averaging $47.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$5K
  • Si-bone, Inc.$535
  • Abbott$371
  • Medtronic$300
  • AbbVie$271
  • Globus Medical$161
  • plus $445 from 9 others

What the payments were for

  • Travel & lodging$2,88541%
  • Food & beverage$4,12259%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,007 in reported general payments places this provider in the 90th percentile of 253 medical providers in Louisiana.

See all medical providers in Louisiana

Medicare billing

Part B allowed, 2024
$13,606
Medicare patients
92
Services billed
229

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin166$1,690
Methocarbamol132$1,032
Diclofenac Sodium67$664
Cyclobenzaprine Hcl127$605
Tizanidine Hcl83$556
Celecoxib32$256
Meloxicam67$246
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen22$238
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen25$235
Baclofen12$145
Tramadol Hcl11$29

Paid to pharmacies, not to this prescriber.

Other medical in Baton Rouge

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →